Home > Arts > Global Pharmaceutical Excipients Market : Market Estimation, Dynamics, Regional Share, Trends, Compe

Global Pharmaceutical Excipients Market : Market Estimation, Dynamics, Regional Share, Trends, Compe

Added: (Tue Oct 10 2017)

Pressbox (Press Release) - (1)Global pharmaceutical excipients market is driven by increase in demand for oral drugs. Factors such as patient compliance and ease in consumption forcing drug manufactures in developing a sustained release dosage formulations which contributes to the extension of shelf life of the oral drugs that adds to the high revenue anticipation of pharmaceutical excipients. However, lack of standard quality policies and regulations for excipients and safety evaluation is expected to hamper the growth of the market over the forecast period.

(2)The Pharmaceutical Excipient Market has been segmented by product, function, end-user, and geography.

(3)On the basis of product, pharmaceutical excipient market is segmented as:
Inorganic Chemicals
Calcium Phosphates
Calcium Carbonate
Calcium Sulphate
Metallic Oxides
Organic Chemicals
Glycols (alcohol)
Povidones polymers
Mineral Hydrocarbons
Gelatin (Proteins)

(4)On the basis of function, pharmaceutical excipient market is segmented as:
Fillers and diluents
Flavouring agents

(5)On the basis of dosage form, pharmaceutical excipient market is segmented as:

(6)On the basis of the end-user, pharmaceutical excipient market is segmented as:
Biotech Companies
Pharmaceutical companies
Research institutes

(7)Global pharmaceutical excipient market is driven by growing demand for oral pharmaceuticals (solid) and development of novel therapeutics because of increase in pharmaceutical industries. The combination of nanotechnology and drug formulations in excipients led the development of nano-derived liposomes, vaccines, and nano coated tablets. The global pharmaceutical excipient market is expected to grow at a significant CAGR over the forecast period owing to increase in utilization of parenteral products, rise in the global burden of chronic & lifestyle diseases and increasing investments by the pharmaceutical industry on the development of biologics. Good manufacturing and distribution practices for for uniform excipients, spanning regions by international regulatory authorities is set to define the market landscape of the excipient industry over the forecast period. Business expansions, new product launches, mergers & acquisitions and collaborations with educational universities are the key strategies adopted by most companies in the global pharmaceutical excipients market.

(8)The global market of pharmaceutical excipients is segmented into 5 key regions, North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa.. North America followed Europe dominates in terms of the size of the excipients market globally. Emerging market like Asia-Pacific is expected to show lucrative growth opportunity owing to the availability of lower labour cost, skilled work force in and low cost of raw materials. Countries such as Brazil, India, and China are expected to be the major contributors to the growth of pharmaceutical excipients market owing to rising percapita income and most of the companies present in developed regions willing to establish manufacturing facilities in developing regions due to their low cost of manufacturing and processing.

(9)Some of the players operating in global pharmaceutical excipients market are Ashland Inc.(U.S.), AkzoNobel (Netherlands), The DOW Chemical Company (U.S.), Archer Daniels Midland Company(U.S.), Associated British Foods PLC (UK), Colorcon, Inc.(U.S.), BASF SE(Germany), Evonik Industries AG (Germany), Innophos Holdings Inc. (U.S.), J.M. Huber Corporation (U.S.), FMC Corporation (U.S.), Roquette Group (Nord-Pas de Calais), Croda International PLC (UK),Merck KGaA (U.S.) and Lubrizol Corporation (U.S.) to name a few.

Submitted by:Rajesh
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.co.uk together with the url of the release.